Let me just start by saying that when multinational companies, even if they are U.S.-based multinationals...the way the supply chain works in North America, it's a North American product mandate. So there are a number of U.S.-based companies that will produce a product line just in Canada, for the reason that we may have a competitive advantage, whether it's in logistics or whether it's in commodity input prices, or whatever the reason might be.
On your point about the Bioterrorism Act, I don't think we can assume that this will affect Canadian companies more than it will affect multinationals, because I think some of the multinationals will be significantly impacted by this.